Inhibitory effects of lodoxamide an eosinophil activation

International Archives of Allergy and Immunology

Volumn 116, Issue 2, 1998, Pages 140-146

  Capron, M ^a   Loiseau, S ^a   Papin, J P ^a   Robertson, S ^b   Capron, A ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b ALCON RESEARCH LTD   (United States)

Author keywords

Chemotaxis; Cytotoxicity; Degranulation; Eosinophils; Human; Lodoxamide

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE RELEASE INHIBITOR; INTERLEUKIN 5; LODOXAMIDE; NEUROTOXIN; PEROXIDASE;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CHEMOTAXIS; EOSINOPHIL; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BLOOD PROTEINS; CHEMOTAXIS, LEUKOCYTE; CYTOPLASMIC GRANULES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL PEROXIDASE; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; HUMANS; OXAMIC ACID; PEROXIDASES; PROTEINS; RATS; RIBONUCLEASES;

EID: 0031831888     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023937     Document Type: Article

References (19)

1. Gleich GJ, Adolphson CR: The eosinophil leukocyte. Adv Immunol 1986;39:177-253.
2. Capron M, Grangette C, Torpier G, Capron A: The second receptor for IgE in eosinophil effector function. Chem Immunol 1989;47:128-178.
3. Soussi Gounni A, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M: High affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994;367:183-186.
4. Lamkhioued B, Soussi Gounni A, Gruart A, Pierce A, Capron A, Capron M: Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol 1995;25:117-125.
5. Tomassini M, Tsicopoulos A, Tai PC, Gruart V, Tonnel AB, Prin L, Capron A, Capron M: Release of granule proteins by eosinophils from allergic and other hypereosinophilic patients upon immunoglobulin dependent activation. J Allergy Clin Immunol 1991;88:365-375.
6. Trocme SD, Aldave AJ: The eye and the eosinophil. Surv Ophthalmol 1994;39:241-252.
7. Fahy GT, Easty DL, Collum LMT, Benedict-Smith A, Hillery M, Parsons DG: Randomised double masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study. Eur J Ophthalmol 1992;2:144-149.
8. Cerqueti PM, Ricca V, Tosca MA, Buscaglia S, Ciprandi G: Lodoxamide treatment of allergic conjunctivitis. Int Arch Allergy Immunol 1994; 105:185-189.
9. Bonini St, Schiavone M, Bonini Se, Magrini L, Lischetti P, Lambiase A, Bucci MG: Efficacy of lodoxamide on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Ophthalmology 1997;104:849-853.
10. Desreumaux P, Capron M: Eosinophils in allergic reactions. Curr Opin Immunol 1996;8:790-795.
11. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ: IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-2400.
12. Aldebert D, Lamkhioued B, Desaint C, Soussi Gounni A, Goldman M, Capron A, Prin L, Capron M: Eosinophils express a functional receptor for interferon a: Inhibitory role of Interferon α on the release of mediators. Blood 1996;87: 2354-2360.
13. Capron M, Rousseaux J, Mazingue C, Bazin H, Capron A: Rat mast-cell eosinophil interaction in antibody-dependent eosinophil cytotoxicity to S. mansoni schistosomula. J Immunol 1978; 121:2518-2525.
14. Leprevost C, Capron M, De Vos C, Tomassini M, Capron A: Inhibition of eosinophil chemotaxis by a new anti-allergic compound (cetirizine). Int Arch Allergy Appl Immunol 1988;87: 9-13.
15. Johnson HG, Sheridan AQ: The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma. Agents Actions 1986;18:301-305.
16. Yanni JM, Weimer LK, Glaser RL, Lang LS, Robertson SM, Spellman JM: Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats. Int Arch Allergy Immunol 1993;101:102-106.
17. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ: Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-646.
18. Capron M, Tomassini M, Van der Vorst E, Kusnierz JP, Papin JP, Capron A: Existence et fonctions d'un récepteur pour I'immunoglobuline A sur les éosinophiles humains. CR Acad Sci Immunol 1988;307:397-402.
19. Grezel D, Capron M, Grzych JM, Fontaine J, Lecocq JP, Capron A: Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: Effector mechanisms involving IgE and IgA antibodies. Eur J Immunol 1993;23:455-460.